EUVIMEDEUVIMED entdecken
Crossref

Recent advances in melasma

Manas Chatterjee, Biju Vasudevan

Pigment International · 2014

DOI: 10.4103/2349-5847.147044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment International, 2014. Verfasst von Manas Chatterjee und 1 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melasma is one of the most common pigmentary disorders worldwide with a still unresolved pathogenesis and treatment continues to be challenging. Increased sun exposure and genetic factors are considered the two most important etiological factors. Estrogens, progesterones and increased melanocyte stimulating hormone are also involved. Melasma treatment can be very frustrating as many modalities can turn out to be ineffective. Dermal and mixed variants are quite resistant to therapy. Most patients seek medical help much after the onset of the condition, making treatment even more difficult. Sunscreens and topical depigmenting agents remain mainstay of therapy. Chemical peels and light sources are beneficial as adjuncts. There have been numerous advances in the understanding and management of melasma. This review attempts to look at these newer vistas in melasma. Literature search for the review was done from PubMed, the Cochrane Library, MEDLINE and Embase using the key word melisma, melasma pathogenesis and melasma treatment.

Zitieren

APA

Chatterjee, M., & Vasudevan, B. (2014). Recent advances in melasma. Pigment International. https://doi.org/10.4103/2349-5847.147044

Vancouver

Chatterjee M, Vasudevan B. Recent advances in melasma. Pigment International. 2014. doi:10.4103/2349-5847.147044

BibTeX
@article{Chatterjee2014,
  author = {Chatterjee, Manas and Vasudevan, Biju},
  title = {Recent advances in melasma},
  journal = {Pigment International},
  year = {2014},
  doi = {10.4103/2349-5847.147044}
}
Kostenlos starten →